EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.

EYEPOINT PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Citadel Advisors 57,700$461,0230.00%
Citadel Advisors 29,100$232,5090.00%
Nuveen Asset Management, LLC 175,862$1,405,1380.00%
AQR Capital Management 15,328$122,4710.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 164,700$1,315,9530.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 66,000$527,3400.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 125,680$1,004,1830.00%
Washington Trust Advisors, Inc. 332$2,6530.00%
Cutler Group LLC / CA 9,600$40.00%
ALLIANCEBERNSTEIN L.P. 19,820$158,3620.00%
RHUMBLINE ADVISERS 41,752$333,5850.00%
MASSMUTUAL TRUST CO FSB/ADV 108$8630.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 5,779$46,1740.00%
Qube Research & Technologies Ltd 10,106$80,7470.00%
FMR LLC 2,397$19,1520.00%
OSAIC HOLDINGS, INC. 17,970$143,5800.00%
DIMENSIONAL FUND ADVISORS LP 50,121$400,4670.00%
VOYA INVESTMENT MANAGEMENT LLC 10,742$85,8290.00%
BANK OF AMERICA CORP /DE/ 7,560$60,4050.00%
WELLS FARGO & COMPANY/MN 8,290$66,2370.00%
External links

This page lists EYEPOINT PHARMACEUTICALS INC's shareholders in Q3 2023. To view EYEPOINT PHARMACEUTICALS INC's shareholder history, click here.